During the last session, Ocular Therapeutix Inc (NASDAQ:OCUL)’s traded shares were 3.95 million, with the beta value of the company hitting 1.44. At the end of the trading day, the stock’s price was $4.64, reflecting an intraday loss of -7.10% or -$0.36. The 52-week high for the OCUL share is $11.31, that puts it down -143.75 from that peak though still a striking 56.9% gain since the share price plummeted to a 52-week low of $2.00. The company’s market capitalization is $690.39M, and the average trade volume was 2.32 million shares over the past three months.
Ocular Therapeutix Inc (NASDAQ:OCUL) trade information
Ocular Therapeutix Inc (OCUL) registered a -7.10% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -7.10% in intraday trading to $4.64, hitting a weekly high. The stock’s 5-day price performance is -38.72%, and it has moved by -50.64% in 30 days. Based on these gigs, the overall price performance for the year is -25.08%.
Ocular Therapeutix Inc (OCUL) estimates and forecasts
Statistics show that Ocular Therapeutix Inc has outperformed its competitors in share price, compared to the industry in which it operates. Ocular Therapeutix Inc (OCUL) shares have gone up 100.22% during the last six months, with a year-to-date growth rate more than the industry average at 33.33% against 10.10.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 8.38%. While earnings are projected to return 17.45% in 2024.
OCUL Dividends
Ocular Therapeutix Inc is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
